Matches in Wikidata for { <http://www.wikidata.org/entity/Q65536126> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q65536126 description "clinical trial" @default.
- Q65536126 description "ensayu clínicu" @default.
- Q65536126 description "klinisch onderzoek" @default.
- Q65536126 description "клінічне випробування" @default.
- Q65536126 name "Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes" @default.
- Q65536126 name "Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes" @default.
- Q65536126 type Item @default.
- Q65536126 label "Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes" @default.
- Q65536126 label "Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes" @default.
- Q65536126 prefLabel "Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes" @default.
- Q65536126 prefLabel "Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes" @default.
- Q65536126 P1050 Q65536126-561E7663-DD78-4B3B-994F-70C0740253B9 @default.
- Q65536126 P1132 Q65536126-581572FA-FCCA-4FFA-BCE4-932659BFE43B @default.
- Q65536126 P1476 Q65536126-187135CD-269B-4798-BAF1-9FE703C00BDC @default.
- Q65536126 P17 Q65536126-02E0FB1F-1D30-4357-8E52-5AAB77E58253 @default.
- Q65536126 P17 Q65536126-1AE0169C-EBF9-486E-B2AF-F33A722E2DFB @default.
- Q65536126 P17 Q65536126-37A778BB-76B9-4735-92E4-1E9D78C9D10E @default.
- Q65536126 P17 Q65536126-4FAA4B80-D59F-4F1B-98BC-6251492B3101 @default.
- Q65536126 P17 Q65536126-608F46EB-B8D8-484E-B44C-382F82855A91 @default.
- Q65536126 P17 Q65536126-78051DEC-C7AD-4686-B3F0-6D8FAE44C5F8 @default.
- Q65536126 P17 Q65536126-80CF6BF8-69A0-41BA-9977-2DF73776A983 @default.
- Q65536126 P17 Q65536126-810D653E-24E7-48A1-9712-3D9CDBC7A647 @default.
- Q65536126 P17 Q65536126-84B8EF48-8851-4746-8A06-80B7DD424B91 @default.
- Q65536126 P17 Q65536126-ADCE6773-3B59-4225-8570-70AC8838997E @default.
- Q65536126 P17 Q65536126-D6E6059A-0111-4CF6-AD9B-8B0096463492 @default.
- Q65536126 P17 Q65536126-DF6F07B6-2A06-4101-9D0F-CD4EC50A96E1 @default.
- Q65536126 P1813 Q65536126-6E692595-B1B9-49D0-B3C0-5598C96EECFA @default.
- Q65536126 P2899 Q65536126-9875457D-0854-4878-8E31-F7FC77553624 @default.
- Q65536126 P3098 Q65536126-E544D084-85BF-446F-8920-F68C833C7395 @default.
- Q65536126 P31 Q65536126-572EA0A3-0BD2-43DF-9AB9-573F8F78F66D @default.
- Q65536126 P580 Q65536126-7AE1F581-4E3E-442D-8C01-5D5066AF32A4 @default.
- Q65536126 P582 Q65536126-E4495470-9B5C-480A-A290-F6A2E374A772 @default.
- Q65536126 P6099 Q65536126-2DDBA937-9D81-4089-BA49-C18602313B48 @default.
- Q65536126 P6153 Q65536126-DEE19EF9-2C3C-40DA-93F0-7466912E94F1 @default.
- Q65536126 P8363 Q65536126-75F7A88F-AEC5-4589-8658-21CFA08DA58F @default.
- Q65536126 P1050 Q12206 @default.
- Q65536126 P1132 "+687" @default.
- Q65536126 P1476 "A 26 Week Randomised, Controlled, Open Label, Multicentre, Multinational, Three-arm, Treat to Target Trial Comparing Efficacy and Safety of Three Different Dosing Regimens of Either Soluble Insulin Basal Analogue (SIBA) or Insulin Glargine With or Without Combination With OAD Treatment, in Subjects With Type 2 Diabetes Mellitus (BEGIN™ : FLEX)" @default.
- Q65536126 P17 Q145 @default.
- Q65536126 P17 Q20 @default.
- Q65536126 P17 Q258 @default.
- Q65536126 P17 Q28 @default.
- Q65536126 P17 Q33 @default.
- Q65536126 P17 Q403 @default.
- Q65536126 P17 Q414 @default.
- Q65536126 P17 Q668 @default.
- Q65536126 P17 Q801 @default.
- Q65536126 P17 Q833 @default.
- Q65536126 P17 Q865 @default.
- Q65536126 P17 Q96 @default.
- Q65536126 P1813 "BEGIN™" @default.
- Q65536126 P2899 "+18" @default.
- Q65536126 P3098 "NCT01006291" @default.
- Q65536126 P31 Q30612 @default.
- Q65536126 P580 "2009-11-01T00:00:00Z" @default.
- Q65536126 P582 "2010-09-01T00:00:00Z" @default.
- Q65536126 P6099 Q42824827 @default.
- Q65536126 P6153 Q818846 @default.
- Q65536126 P8363 Q78089383 @default.